Lars Henrikson
Director/Board Member chez XVIVO PERFUSION AB
Fortune : 33 434 $ au 31/03/2024
Profil
Lars Henrikson is currently the Director at Xvivo Perfusion AB and also holds a Director position at AddBIO AB.
He previously held the position of Vice President-Marketing & Business Development at Dentsply IH, Inc. and Wellspect HealthCare AB.
He was also the Executive Vice President at Wellspect AG and Dentsply Sweden AB.
Mr. Henrikson holds a doctorate degree from the University of Gothenburg.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
XVIVO PERFUSION AB
0,00% | 24/04/2023 | 1 300 ( 0,00% ) | 33 434 $ | 31/03/2024 |
Postes actifs de Lars Henrikson
| Sociétés | Poste | Début |
|---|---|---|
| XVIVO PERFUSION AB | Director/Board Member | 01/01/2020 |
Dentsply IH, Inc.
 Dentsply IH, Inc. Medical SpecialtiesHealth Technology Dentsply IH, Inc. provides medical devices for dentistry and urology. It develops, manufactures, and markets healthcare devices for single use and medical implants. The company was founded in 1948 and is headquartered in Waltham, MA. | Sales & Marketing | - |
AddBIO AB
 AddBIO AB BiotechnologyHealth Technology AddBIO AB provides bone implant technology solutions. It offers Zolidd, a bioactive nanolayer with a bone strengthening drug. The firm's Zolidd is used in the areas of dental and trauma implants. It also offers Zolidiser, a machine to add bone-strengthening drugs to implants. The company was founded by Per Aspenberg and Trine Vikinge in 2008 and is headquartered in Linköping, Sweden. | Director/Board Member | - |
Anciens postes connus de Lars Henrikson
| Sociétés | Poste | Fin |
|---|---|---|
Wellspect HealthCare AB
 Wellspect HealthCare AB Medical SpecialtiesHealth Technology Wellspect HealthCare AB develops, manufactures, and markets dental, urological, surgical, and medical products. Its products include LoFric Primo, LoFric Plus, LoFric Cath-Kit, LoFric Hydro-Kit II, and LoFric Dila-Cath. The company was founded in 1948 and is headquartered in Molndal, Sweden.. | Sales & Marketing | 31/07/2018 |
Wellspect AG
 Wellspect AG Medical SpecialtiesHealth Technology Part of Dentsply Sirona, Inc., Wellspect AG is a Swedish company that manufactures dental implants. The private company is based in Malmö, Sweden. Wellspect was acquired by Wellspect HealthCare AB, part of Dentsply Sirona, Inc. from August 31, 2011 on July 01, 2005. | Corporate Officer/Principal | - |
| Dentsply Sweden AB | Corporate Officer/Principal | - |
Formation de Lars Henrikson
| University of Gothenburg | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| XVIVO PERFUSION AB | Health Technology |
| Entreprise privées | 5 |
|---|---|
Dentsply IH, Inc.
Dentsply IH, Inc. Medical SpecialtiesHealth Technology Dentsply IH, Inc. provides medical devices for dentistry and urology. It develops, manufactures, and markets healthcare devices for single use and medical implants. The company was founded in 1948 and is headquartered in Waltham, MA. | Health Technology |
Wellspect HealthCare AB
Wellspect HealthCare AB Medical SpecialtiesHealth Technology Wellspect HealthCare AB develops, manufactures, and markets dental, urological, surgical, and medical products. Its products include LoFric Primo, LoFric Plus, LoFric Cath-Kit, LoFric Hydro-Kit II, and LoFric Dila-Cath. The company was founded in 1948 and is headquartered in Molndal, Sweden.. | Health Technology |
Wellspect AG
Wellspect AG Medical SpecialtiesHealth Technology Part of Dentsply Sirona, Inc., Wellspect AG is a Swedish company that manufactures dental implants. The private company is based in Malmö, Sweden. Wellspect was acquired by Wellspect HealthCare AB, part of Dentsply Sirona, Inc. from August 31, 2011 on July 01, 2005. | Health Technology |
AddBIO AB
AddBIO AB BiotechnologyHealth Technology AddBIO AB provides bone implant technology solutions. It offers Zolidd, a bioactive nanolayer with a bone strengthening drug. The firm's Zolidd is used in the areas of dental and trauma implants. It also offers Zolidiser, a machine to add bone-strengthening drugs to implants. The company was founded by Per Aspenberg and Trine Vikinge in 2008 and is headquartered in Linköping, Sweden. | Health Technology |
| Dentsply Sweden AB |
